RNP (Ribonucleoprotein) antibodies are autoantibodies that target components of the body’s cells, particularly the U1-RNP complex, and are a key marker for diagnosing autoimmune diseases, especially Mixed Connective Tissue Disease (MCTD), where high levels are diagnostic, but they’re also found in Systemic Lupus Erythematosus (SLE) and scleroderma, often with overlapping symptoms like arthritis, Raynaud’s, and fatigue.
A positive test when Anti-SM is detected, but can be detected in some patients with systemic lupus patients in the absence of Anti-Sm.
May be found in other autoimmune connective tissue disease aside from SLE.
Associated with high levels in mixed connective tissue disease.
Their specific significance depends on the patient’s symptoms and other autoantibodies, indicating the immune system mistakenly attacks its own tissues.
Autoantibodies: RNP antibodies target RNP (ribonucleoprotein) particles within cells, which are vital for gene expression.
They often show up as a speckled pattern in antinuclear antibody (ANA) tests, indicating an autoimmune condition.
Associated Conditions:
Mixed Connective Tissue Disease (MCTD): High levels are considered diagnostic for MCTD, an overlap syndrome with features of lupus, scleroderma, and polymyositis.
Systemic Lupus Erythematosus (SLE) (Lupus): Found in many lupus patients, often alongside anti-Sm antibodies, and linked to milder renal involvement.
Scleroderma & Sjögren’s Syndrome: Also associated with these connective tissue diseases.
The presence of RNP antibodies alone doesn’t define a specific disease.
Common Symptoms: Raynaud’s phenomenon (fingers/toes turn white/blue). Arthritis (joint pain/swelling). Fatigue and weakness. Fever, weight loss.